Mathieu C - Search Results

1

The scientific evidence: vildagliptin and the benefits of islet enhancement.

Mathieu C. Mathieu C. Diabetes Obes Metab. 2009 May;11 Suppl 2:9-17. doi: 10.1111/j.1463-1326.2008.01033.x. Diabetes Obes Metab. 2009. PMID: 19385979 Review.

2

Glucagon-like peptide-1: modulator of β-cell dysfunction and death.

Rondas D, D'Hertog W, Overbergh L, Mathieu C. Rondas D, et al. Among authors: mathieu c. Diabetes Obes Metab. 2013 Sep;15 Suppl 3:185-92. doi: 10.1111/dom.12165. Diabetes Obes Metab. 2013. PMID: 24003936 Review.

3

A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON).

Mathieu C, Rodbard HW, Cariou B, Handelsman Y, Philis-Tsimikas A, Ocampo Francisco AM, Rana A, Zinman B; BEGIN: VICTOZA ADD-ON (NN1250-3948) study group. Mathieu C, et al. Diabetes Obes Metab. 2014 Jul;16(7):636-44. doi: 10.1111/dom.12262. Epub 2014 Feb 11. Diabetes Obes Metab. 2014. PMID: 24443830 Clinical Trial.

4

Reaching glycaemic targets while minimizing hypoglycaemia in insulin-treated type 2 diabetes patients.

Mathieu C, Robbrecht S. Mathieu C, et al. Diabetes Obes Metab. 2008 Jul;10 Suppl 2:14-23. doi: 10.1111/j.1463-1326.2008.00841.x. Diabetes Obes Metab. 2008. PMID: 18577153

5

Efficacy and safety of triple therapy with dapagliflozin add-on to saxagliptin plus metformin over 52 weeks in patients with type 2 diabetes.

Mathieu C, Herrera Marmolejo M, González González JG, Hansen L, Chen H, Johnsson E, Garcia-Sanchez R, Iqbal N. Mathieu C, et al. Diabetes Obes Metab. 2016 Nov;18(11):1134-1137. doi: 10.1111/dom.12737. Epub 2016 Aug 19. Diabetes Obes Metab. 2016. PMID: 27385192 Clinical Trial.

6

Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes.

Fulcher G, Matthews DR, Perkovic V, de Zeeuw D, Mahaffey KW, Mathieu C, Woo V, Wysham C, Capuano G, Desai M, Shaw W, Vercruysse F, Meininger G, Neal B; CANVAS trial collaborative group. Fulcher G, et al. Among authors: mathieu c. Diabetes Obes Metab. 2016 Jan;18(1):82-91. doi: 10.1111/dom.12589. Epub 2015 Dec 8. Diabetes Obes Metab. 2016. PMID: 26450639 Clinical Trial.

7

β-Cell differentiation and regeneration in type 1 diabetes.

Ding L, Gysemans C, Mathieu C. Ding L, et al. Among authors: mathieu c. Diabetes Obes Metab. 2013 Sep;15 Suppl 3:98-104. doi: 10.1111/dom.12164. Diabetes Obes Metab. 2013. PMID: 24003926 Review.

8

Effectiveness of vildagliptin versus other oral antidiabetes drugs as add-on to sulphonylurea monotherapy: Post hoc analysis from the EDGE study.

Prasanna Kumar KM, Phadke U, Brath H, Gawai A, Paldánius PM, Mathieu C. Prasanna Kumar KM, et al. Among authors: mathieu c. Prim Care Diabetes. 2016 Dec;10(6):452-458. doi: 10.1016/j.pcd.2016.06.001. Epub 2016 Jun 25. Prim Care Diabetes. 2016. PMID: 27353459 Free article.

9

Can we reduce hypoglycaemia with insulin detemir?

Mathieu C. Mathieu C. Int J Obes Relat Metab Disord. 2004 Sep;28 Suppl 2:S35-40. doi: 10.1038/sj.ijo.0802748. Int J Obes Relat Metab Disord. 2004. PMID: 15306836 Review.

10

A comparison between simplified and intensive dose-titration algorithms using AIR inhaled insulin for insulin-naive patients with type 2 diabetes in a randomized noninferiority trial.

Mathieu C, Cuddihy R, Arakaki RF, Belin RM, Planquois JM, Lyons JN, Heilmann CR. Mathieu C, et al. Diabetes Technol Ther. 2009 Sep;11 Suppl 2:S53-61. doi: 10.1089/dia.2009.0036. Diabetes Technol Ther. 2009. PMID: 19772450 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,208 results

Search Page

Filters